Sun Pharma recalls 55,000 bottles of generic drug from US market due to manufacturing norms violation

Sun Pharma is recalling 55,000 bottles of Febuxostat Tablets, in 40 mg and 80 mg strengths, from the American market due to manufacturing practice deviations caused by microbial contamination at their Dadra-based plant.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/FmKypDU
via IFTTT